JP2016501013A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016501013A5 JP2016501013A5 JP2015541144A JP2015541144A JP2016501013A5 JP 2016501013 A5 JP2016501013 A5 JP 2016501013A5 JP 2015541144 A JP2015541144 A JP 2015541144A JP 2015541144 A JP2015541144 A JP 2015541144A JP 2016501013 A5 JP2016501013 A5 JP 2016501013A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- vitro
- cell activator
- γδt
- activator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940126530 T cell activator Drugs 0.000 claims 9
- 238000000338 in vitro Methods 0.000 claims 8
- 210000004027 cell Anatomy 0.000 claims 7
- 238000000034 method Methods 0.000 claims 7
- 210000001744 T-lymphocyte Anatomy 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 230000001939 inductive effect Effects 0.000 claims 2
- 230000035755 proliferation Effects 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 230000006052 T cell proliferation Effects 0.000 claims 1
- 239000012190 activator Substances 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 230000005784 autoimmunity Effects 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- YKAYCWPQDPILSA-UHFFFAOYSA-N bromohydrin pyrophosphate Chemical compound BrCC(O)(C)CCOP(O)(=O)OP(O)(O)=O YKAYCWPQDPILSA-UHFFFAOYSA-N 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12306385.1 | 2012-11-08 | ||
| EP12306385 | 2012-11-08 | ||
| PCT/EP2013/073328 WO2014072446A1 (en) | 2012-11-08 | 2013-11-08 | Method for inducing il-2-free proliferation of gamma delta t cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016501013A JP2016501013A (ja) | 2016-01-18 |
| JP2016501013A5 true JP2016501013A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2016-12-28 |
Family
ID=47189860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015541144A Pending JP2016501013A (ja) | 2012-11-08 | 2013-11-08 | γδＴ細胞の無ＩＬ−２増殖を誘導するための方法 |
Country Status (4)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20170080604A (ko) | 2014-11-10 | 2017-07-10 | 제넨테크, 인크. | 항-인터류킨-33 항체 및 그것의 용도 |
| US20160168640A1 (en) | 2014-11-10 | 2016-06-16 | Genentech, Inc. | Therapeutic and diagnostic methods for il-33-mediated disorders |
| WO2016081518A2 (en) | 2014-11-17 | 2016-05-26 | Adicet Bio, Inc. | Engineered gamma delta t-cells |
| US20170360907A1 (en) | 2014-12-04 | 2017-12-21 | The University Of North Carolina At Chapel Hill | Compositions and methods for preventing and treating graft versus host disease |
| WO2017197347A1 (en) | 2016-05-12 | 2017-11-16 | Adicet Bio, Inc. | METHODS FOR SELECTIVE EXPANSION OF γδ T-CELL POPULATIONS AND COMPOSITIONS THEREOF |
| WO2018022575A1 (en) * | 2016-07-26 | 2018-02-01 | University Of Virginia Patent Foundation | Compositions and methods for treating clostridium difficile infection |
| CN108310367A (zh) * | 2017-01-18 | 2018-07-24 | 复旦大学 | 白介素33（il-33）在制备抗乙型肝炎病毒制剂中的用途 |
| CN110944658A (zh) * | 2017-05-18 | 2020-03-31 | Umc乌德勒支控股有限公司 | 用于细胞靶向疗法的组合物和方法 |
| KR20200098518A (ko) | 2017-11-15 | 2020-08-20 | 아디셋 바이오, 인크. | δ3 γδ T-세포 집단의 선택적 증식을 위한 방법 및 이의 조성물 |
| DE102017127984B4 (de) | 2017-11-27 | 2019-12-05 | Immatics US, Inc. | Verfahren für die Vermehrung und Aktivierung von γδ-T-Zellen |
| CA3114292A1 (en) * | 2018-09-27 | 2020-04-02 | Phosphogam, Inc. | Methods and compositions for the expansion and use of allogeneic gamma/delta-t cells |
| CN109517793B (zh) * | 2018-11-30 | 2022-05-10 | 广州长峰生物技术有限公司 | 一种NK细胞和γδT细胞共培养的建立方法 |
| MX2021006503A (es) * | 2018-12-03 | 2021-08-05 | Adicet Bio Inc | Métodos para la expansión in vivo selectiva de poblaciones de células t gamma delta y composiciones de estas. |
| EP4118114A1 (en) | 2020-03-13 | 2023-01-18 | Genentech, Inc. | Anti-interleukin-33 antibodies and uses thereof |
| CN118354786A (zh) * | 2021-11-04 | 2024-07-16 | 纪念斯隆-凯特琳癌症中心 | Il33蛋白及其使用方法 |
| WO2023132926A2 (en) * | 2022-01-04 | 2023-07-13 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Compositions and methods for treating cancer |
| JPWO2023176896A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 2022-03-18 | 2023-09-21 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2782721B1 (fr) * | 1998-09-01 | 2000-11-03 | Inst Nat Sante Rech Med | Nouveaux composes phosphohalohydrines, procede de fabrication et applications |
| EP1426052B1 (en) * | 2002-12-02 | 2009-09-02 | Innate Pharma | Compositions comprising interleukin-2 and gamma-delta T cell activator and uses thereof |
| US20070134273A1 (en) * | 2004-02-10 | 2007-06-14 | Francois Romagne | Composition and method for the treatment of carcinoma |
| ITRM20070437A1 (it) * | 2007-08-10 | 2009-02-11 | Istituto Naz Per Le Malattie I | Metodo per la generazione ed espansione di cellule t gamma/delta regolatorie cellule cosi' ottenute e loro impieghi |
| JP2010004853A (ja) * | 2008-06-30 | 2010-01-14 | Japan Health Science Foundation | 制御性ｔ細胞の製造方法 |
-
2013
- 2013-11-08 US US14/440,921 patent/US20150259645A1/en not_active Abandoned
- 2013-11-08 JP JP2015541144A patent/JP2016501013A/ja active Pending
- 2013-11-08 EP EP13791776.1A patent/EP2916858A1/en not_active Withdrawn
- 2013-11-08 WO PCT/EP2013/073328 patent/WO2014072446A1/en active Application Filing
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016501013A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| JP2017524031A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| WO2016070166A3 (en) | Messenger una molecules and uses thereof | |
| HK1203489A1 (en) | Purinone compounds as kinase inhibitors | |
| JP2018512047A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| EA201401281A1 (ru) | D-аминокислотные химические соединения для лечения заболеваний печени | |
| EA201290131A1 (ru) | Производные пурина или деазапурина для применения при лечении вирусных инфекций и других заболеваний | |
| WO2015048689A8 (en) | Inhibitors of bruton's tyrosine kinase | |
| WO2015031771A3 (en) | Administration of kynurenine depleting enzymes for tumor therapy | |
| BR112014018524A2 (pt) | derivados de pirimido [4,5-b]indol e métodos de utilização dos mesmos na expansão de células-tronco hematopoiéticas, composição farmacêutica e kits | |
| MX2009006786A (es) | Composiciones y metodos para el tratamiento de infecciones y tumores. | |
| CO7350624A2 (es) | Inhibidores de la tirosina-quinasa de bruton | |
| NZ609201A (en) | Means and methods for treating dlbcl | |
| WO2015035136A8 (en) | Delivery system for functional nucleases | |
| BR112015022625A8 (pt) | microarranjo para entrega de agente terapêutico e métodos de utilização | |
| MD20140035A2 (ro) | Metodă de tratament al hepatitei virale C | |
| WO2018005521A3 (en) | Cell culture chambers and methods of use thereof | |
| CL2013000018A1 (es) | Compuestos derivados de indolizina , su procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento del cancer, entre otros. | |
| EP2743266A4 (en) | PROTEIN KINASE INHIBITORS (VARIANTS), THEIR USE FOR THE TREATMENT OF ONCOLOGICAL DISEASES AND PHARMACEUTICAL COMPOSITION BASED THEREFROM | |
| EP3826624A4 (en) | USE OF ANTI-CD2 ANTIBODY (ADC) DRUG CONJUGATE IN ALLOGENIC CELL THERAPY | |
| CL2020001358A1 (es) | Cepa vacunal de brucella modificada para el tratamiento de brucelosis | |
| BR112013033544A2 (pt) | dosagem e administração de anticorpos anti-erbb3 em combinação com paclitaxel para tratamento de cânceres ginecológicos | |
| IL222343B (en) | Compositions comprising allogeneic th1 cells and inf-gamma for treating cancer or infectious diseases | |
| EA032977B1 (ru) | Генетически стабильный онколитический рнк вирус, способ его производства и применения | |
| HK1219962A1 (zh) | 人抗白细胞介素-32抗体 |